Blog
The latest news and articles
Actoverco’s CEO resigned
According to Actoverco’s Public Relations, Shahram Shini, CEO of Actoverco, has recently resigned.
Another big step of Iran in the production of anti-cancer drugs
The largest factory for the production of anti-cancer drugs in the Middle East, as well as the biotechnology department of the pharmaceutical group, was put into operation in Alborz with the presence of the Minister of Health.
Actoverco received 90.8 million Euros of governmental currency in the first half of this year
The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”
We do not talk, we act
Shini, CEO of Actoverco on the sidelines of ICCU 2018 in a conversation with PHANA: With proper planning, none of the Actoverco’s drugs will not experience a shortage. We have…
With the lifting of sanctions, many announced their readiness to work with “Actoverco
We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.
Conferences and Exhibitions
